Clinical Trial

Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this protocol is to compare neoadjuvant chemoradiation plus consolidation chemotherapy before surgical resection with the standard neoadjuvant chemoradiation followed by surgical resection and adjuvant chemotherapy in patients with rectal cancer.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-08-09; most recent amendment 2024-10-07.
Status change: Not Yet Recruiting → Recruiting 2022-09-08
Trial Details
NCT Number NCT05496491
Lead Sponsor Larissa University Hospital
Conditions Rectal Neoplasms
Enrollment 84 participants
Start Date 2022-08-30
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2024-10-08